Getein Biotech Showcases Latest POCT Analyzers

By LabMedica International staff writers
Posted on 13 Nov 2024

Image: Getein Biotech’s latest IVD and POCT solutions are being highlighted at MEDICA 2024 (Photo courtesy of Getein)

Getein Biotech, Inc. (Nanjing, China) is showcasing its latest IVD and POCT solutions at MEDICA 2024.

At this year’s MEDICA, Getein Biotech is presenting the MAGICL 6000 compact and innovative chemiluminescence immunoassay analyzer designed for mid to high-workflow laboratories that need a one-step chemiluminescence solution. Highly productive and compact, this instrument enables fully automated operation and provides the fastest testing speed of any device of its size. Alongside, Getein is highlighting the Getein 1200 immunofluorescence quantitative analyzer, a truly automated, modular, intelligent and dry system. The instrument has a low failure rate and moderate measurement speed, which is convenient for clinical departments with medium and high throughput use. Visitors to the Getein booth can also experience the Getein 1160 immunofluorescence quantitative analyzer which has four incubation channels and one emergency test channel, and a constant test environment with 32℃ to ensure more accurate test results.

Among its molecular diagnostic solutions, Getein is presenting the GN 7000 Akso PCR system, a compact and fully automated PCR lab that integrates nucleic acid release, PCR amplification, real-time detection, and result analysis to offer a one-step POCT solution for nucleic acid detection. Getein is also showcasing the Metis 6000 integrated clinical chemistry and immunochemistry modular system which is independently developed and produced. Metis 6000 integrates the MAGICL 6200 immunochemistry module (stand-alone 400 T/h) and CM-1000 clinical chemistry module (stand-alone constant speed 1000 T/h, ISE 400 T/h), and is equipped with the SH 80 sample supply track unit and SHC 200 automatic pre-analytical system. The dual module requires only 2.6m2 of space and provides customers with a more cost-effective menu of more than 180 self-generated chemistries and immunological reagents, which can be widely used in laboratories with different throughputs.

Among its range of diagnostic tests, Getein is showcasing the One Step Test for D-Dimer (Colloidal Gold) which is used as an aid in the assessment and exclusion of suspected deep vein thrombosis (DVT) or pulmonary embolism (PE) in the physical department or emergency room (ER). Additionally, the company is highlighting the Getein Cardiac Troponin l Fast Test Kit (Colloidal Gold) which is intended for the in vitro qualitative and semi-quantitative determination of cardiac Troponin l (cTnl) in serum, plasma or whole blood.

Related Links:
Getein Biotech, Inc.